2012
DOI: 10.1089/jop.2011.0142
|View full text |Cite
|
Sign up to set email alerts
|

Rebamipide Increases the Mucin-Like Glycoprotein Production in Corneal Epithelial Cells

Abstract: Purpose: Dry eye is a multifactorial disease of tears and the ocular surface due to tear deficiency or excessive tear evaporation. Tear film instability is due to a disturbance in ocular surface mucin leading to a dysfunction of mucin, resulting in dry eye. In this study, we examined the effect of rebamipide, an anti-ulcer agent, on glycoconjugate production, as an indicator of mucin-like glycoprotein in cultured corneal epithelial cells. Further, we investigated the effect of rebamipide on the gene expression… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
35
0
7

Year Published

2014
2014
2017
2017

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 71 publications
(44 citation statements)
references
References 28 publications
2
35
0
7
Order By: Relevance
“…Topical rebamipide application induces EGFR expression in the epithelial cells, leading to goblet cell differentiation and an increased number of goblet cells, which subsequently promotes the secretion of mucin to the ocular surface. In addition, EGFR upregulation by rebamipide treatment may also directly stimulate mucin secretion from the goblet cells as reported previously (20).…”
Section: Discussionsupporting
confidence: 67%
“…Topical rebamipide application induces EGFR expression in the epithelial cells, leading to goblet cell differentiation and an increased number of goblet cells, which subsequently promotes the secretion of mucin to the ocular surface. In addition, EGFR upregulation by rebamipide treatment may also directly stimulate mucin secretion from the goblet cells as reported previously (20).…”
Section: Discussionsupporting
confidence: 67%
“…It implies that alterations to the glycans in vivo through dysfunctional post-translational processing or enzymatic digestion of mucin glycans can result in defi cient mucus layers. Drugs such as rebamipide are currently investigated for their capacity to boost mucin production and help restore proper hydration of the mucosa, [ 46 ] but a topical treatment of the mucus with polymers could be a viable alternative. We show that although the simple addition of PEG to the fl uid phase of the lubricant has no effect, immobilizing PEG to the adsorbed mucins greatly enhances hydration and lubrication.…”
Section: Discussionmentioning
confidence: 99%
“…The aim of this study was to evaluate taste-masking effect of CGA on bitter drugs using taste sensor measurements and surface plasmon resonance (SPR) analysis of CGA-drug interactions. Six different bitter drugs were used: amlodipine besylate (AMD), [19][20][21] diphenhydramine hydrochloride (DPH), 22) donepezil hydrochloride (DNP), 6) rebamipide (RBM), 18,23,24) diclofenac sodium (DCF) 25) and etodolac (ETD). 25) These drugs are well-established as bitter medicines and are widely used in clinical practice.…”
Section: Taste-masking Effect Of Chlorogenic Acid (Cga) On Bitter Drumentioning
confidence: 99%